Advanced search
Publication Cover
Cancer Investigation Volume 23, 2005 - Issue 2
Submit an article Journal homepage
115
Views
21
CrossRef citations to date
0
Altmetric
Clinical Science Review

Benefit of Temozolomide Compared to Procarbazine in Treatment of Glioblastoma Multiforme at First Relapse: Effect on Neurological Functioning, Performance Status, and Health Related Quality of Life

Dr. David R Macdonald MEDTAP International, 20 Bloomsbury Square, London, WC1A 2NS, UK; London Regional Cancer Centre, London, Ontario, Canada; London Regional Cancer Centre, 790 Commissioners Road East, London, N6A 4L6, Ontario, Canada
,
Gwendoline Kiebert MEDTAP International, 20 Bloomsbury Square, London, WC1A 2NS, UK
,
Michael Prados MEDTAP International, 20 Bloomsbury Square, London, WC1A 2NS, UK
,
Alfred Yung MEDTAP International, 20 Bloomsbury Square, London, WC1A 2NS, UK
&
Jeffrey Olson MEDTAP International, 20 Bloomsbury Square, London, WC1A 2NS, UK
Pages 138-144 | Published online: 11 Jun 2009

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Rebecca B. Little, Robert A. Oster, Betty E. Darnell, Wendy Demark-Wahnefried & L. Burt Nabors. (2016) Pilot Study to Explore the Accuracy of Current Prediction Equations in Assessing Energy Needs of Patients with Newly Diagnosed Glioblastoma Multiforme. Nutrition and Cancer 68:6, pages 926-934.
Read now
Mark R Gilbert & Terri S Armstrong. (2007) Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomide. Therapeutics and Clinical Risk Management 3:6, pages 1027-1033.
Read now
Martin JB Taphoorn & Andrew Bottomley. (2005) Health-related quality of life and symptom research in glioblastoma multiforme patients. Expert Review of Pharmacoeconomics & Outcomes Research 5:6, pages 763-774.
Read now

Articles from other publishers (18)

Almut Dutz, Linda Agolli, Rebecca Bütof, Chiara Valentini, Michael Baumann, Armin Lühr, Steffen Löck & Mechthild Krause. (2020) Neurocognitive function and quality of life after proton beam therapy for brain tumour patients. Radiotherapy and Oncology 143, pages 108-116.
Crossref
H. Taghizadeh, L. Müllauer, J. Furtner, J. A. Hainfellner, C. Marosi, M. Preusser & G. W. Prager. (2019) Applied Precision Cancer Medicine in Neuro-Oncology. Scientific Reports 9:1.
Crossref
Shohei Tsuji, Yuta Ohno, Shinsuke Nakamura, Tetsuya Yamada, Yasuhiro Noda, Masanao Saio, Toru Iwama, Masamitsu Shimazawa & Hideaki Hara. (2019) Temozolomide has anti-tumor effects through the phosphorylation of cPLA2 on glioblastoma cells. Brain Research 1723, pages 146396.
Crossref
Nicholas G. Avgeropoulos & Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 21 44 .
Andreas Peyrl, Josa Frischer, Johannes A. Hainfellner, Matthias Preusser, Karin Dieckmann & Christine Marosi. 2018. Neuropathology. Neuropathology 547 560 .
Linda Stöckelmaier, Mirjam Renovanz, Jochem König, Katrin Nickel, Anne-Katrin Hickmann, Regine Mayer-Steinacker, Minou Nadji-Ohl, Oliver Ganslandt, Lars Bullinger, Christian Rainer Wirtz & Jan Coburger. (2017) Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life. World Neurosurgery 102, pages 383-399.
Crossref
Frank Schwarm, Florian Uhle, Anne Sch�nzer, Till Acker, Marco Stein, Marcus Reinges, Cornelia Weischer, Marcus Weigand, Eberhard Uhl & Malgorzata Kolodziej. (2016) High-mobility group AT-hook protein 2 expression and its prognostic significance in MGMT methylated and unmethylated glioblastoma. International Journal of Oncology.
Crossref
Olivier L. Chinot, Wolfgang Wick, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Antoine F. Carpentier, Khe Hoang-Xuan, Petr Kavan, Dana Cernea, Alba A. Brandes, Magalie Hilton, Lauren Abrey & Timothy Cloughesy. (2014) Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma. New England Journal of Medicine 370:8, pages 709-722.
Crossref
Jeffrey S. Wefel, Terri A. Armstrong & Sadhna Kohli. 2011. Primary Central Nervous System Tumors. Primary Central Nervous System Tumors 143 170 .
Astrid Erharter, Johannes Giesinger, Georg Kemmler, Gabriele Schauer-Maurer, Guenter Stockhammer, Armin Muigg, Markus Hutterer, Gerhard Rumpold, Barbara Sperner-Unterweger & Bernhard Holzner. (2010) Implementation of Computer-Based Quality-of-Life Monitoring in Brain Tumor Outpatients in Routine Clinical Practice. Journal of Pain and Symptom Management 39:2, pages 219-229.
Crossref
Jin-xiang Cheng, Xiang Zhang & Bo-Lin Liu. (2009) Health-related quality of life in patients with high-grade glioma. Neuro-Oncology 11:1, pages 41-50.
Crossref
Antonio Silvani, Elena Lamperti, Paola Gaviani, Marica Eoli, Anna Fiumani, Andrea Salmaggi, Chiara Falcone, Graziella Filippini, Andrea Botturi & Amerigo Boiardi. (2007) Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients. Journal of Neuro-Oncology 87:2, pages 143-151.
Crossref
Vittorio Donato, Antonella Papaleo, Annamaria Castrichino, Enzo Banelli, Felice GiangasperoMaurizio SalvatiRoberto Delfini. (2018) Prognostic Implication of Clinical and Pathologic Features in Patients with Glioblastoma Multiforme Treated with Concomitant Radiation plus Temozolomide. Tumori Journal 93:3, pages 248-256.
Crossref
Michael S. Bobola, Sridhar Varadarajan, Nolan W. Smith, Ryan D. Goff, Douglas D. Kolstoe, A. Blank, Barry Gold & John R. Silber. (2007) Human Glioma Cell Sensitivity to the Sequence-Specific Alkylating Agent Methyl-Lexitropsin. Clinical Cancer Research 13:2, pages 612-620.
Crossref
Mark R. Gilbert & Frederick F. Lang. (2006) Anaplastic Oligodendroglial Tumors: A Tale of Two Trials. Journal of Clinical Oncology 24:18, pages 2689-2690.
Crossref
G. Henke, T. Kucinski, M. Simon & U. Herrlinger. (2006) Nebenwirkungen der Therapie von HirntumorenSide effects of treatment for brain tumors. Der Onkologe 12:6, pages 546-555.
Crossref
Mark A RosenthalKatharine J DrummondMichael DallyMichael MurphyLawrence CherDavid AshleyVicky ThursfieldGraham G Giles. (2006) Management of glioma in Victoria (1998–2000): retrospective cohort study. Medical Journal of Australia 184:6, pages 270-273.
Crossref
Carsten Nieder & Mark R. Gilbert. 2006. Multimodal Concepts for Integration of Cytotoxic Drugs. Multimodal Concepts for Integration of Cytotoxic Drugs 165 186 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.